Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry-Reference-Cited by-同舟云学术

Management of heart failure with reduced ejection fraction in Europe: design of the ARIADNE registry

Published:2020-02-06 Issue:2 Volume:7 Page:727-736
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Zeymer Uwe¹,Clark Andrew L.²,Barrios Vivencio³,Damy Thibaud⁴,Drożdż Jaroslaw⁵,Fonseca Candida⁶,Lund Lars H.⁷,Di Comite Gabriele⁸,Hupfer Stephan⁹,Maggioni Aldo P.¹⁰

Affiliation:

1. Klinikum Ludwigshafen, Institut für Herzinfarktforschung Ludwigshafen Bremserstrasse 79 Ludwigshafen 67063 Germany

2. Department of Cardiology Hull York Medical School, Castle Hill Hospital Kingston upon Hull UK

3. Department of Cardiology Ramon y Cajal Hospital Madrid Spain

4. Department of Cardiology Henri Mondor Hospital Creteil France

5. Medical University of Lodz Lodz Poland

6. S. Francisco Xavier Hospital, NOVA Medical School, Faculdade de Ciências Médicas Universidade Nova de Lisboa Lisbon Portugal

7. Department of Medicine, Unit of Cardiology Karolinska Institutet Stockholm Sweden

8. Novartis Pharma AG Basel Switzerland

9. Novartis Pharma GmbH Nuernberg Germany

10. Associazione Nazionale Medici Cardiologi Ospedalieri Research Center Florence Italy

Funder

Novartis Pharmaceuticals UK Limited

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12569

Reference34 articles.

1. MANAGEMENT OF END STAGE HEART FAILURE

2. Heart disease and stroke statistics‐2016 update: a report from the American Heart Association;Writing Group;Circulation,2016

3. Nonpharmacologic Measures and Drug Compliance in Patients with Heart Failure: Data from the EuroHeart Failure Survey

4. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

5. Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry;International Journal of Cardiology;2023-01

2. Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry;ESC Heart Failure;2022-09-15

3. Efficacy and Dosage Pattern of Sacubitril/Valsartan in Chinese Heart Failure with Reduced Ejection Fraction Patients;Journal of Cardiovascular Translational Research;2022-05-03

4. Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry;European Heart Journal - Quality of Care and Clinical Outcomes;2021-03-16

5. Analysis of causes of death in patients with implanted defibrillators;Clinical Research in Cardiology;2021-03-09